Value of donor–specific anti–HLA antibody monitoring and characterization for risk stratification of kidney allograft loss
D Viglietti, A Loupy, D Vernerey… - Journal of the …, 2017 - journals.lww.com
The diagnosis system for allograft loss lacks accurate individual risk stratification on the
basis of donor–specific anti–HLA antibody (anti-HLA DSA) characterization. We investigated
whether systematic monitoring of DSA with extensive characterization increases
performance in predicting kidney allograft loss. This prospective study included 851 kidney
recipients transplanted between 2008 and 2010 who were systematically screened for DSA
at transplant, 1 and 2 years post-transplant, and the time of post–transplant clinical events …
basis of donor–specific anti–HLA antibody (anti-HLA DSA) characterization. We investigated
whether systematic monitoring of DSA with extensive characterization increases
performance in predicting kidney allograft loss. This prospective study included 851 kidney
recipients transplanted between 2008 and 2010 who were systematically screened for DSA
at transplant, 1 and 2 years post-transplant, and the time of post–transplant clinical events …